Publicaciones en las que colabora con Daniel Rueda (6)

2017

  1. Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity

    Pharmacogenomics, Vol. 18, Núm. 13, pp. 1215-1223

2015

  1. Detailed characterization of MLH1 p.D41H and p.N710D variants coexisting in a Lynch syndrome family with conserved MLH1 expression tumors

    Clinical Genetics, Vol. 87, Núm. 6, pp. 543-548

2014

  1. Age at onset should be a major criterion for subclassification of colorectal cancer

    Journal of Molecular Diagnostics, Vol. 16, Núm. 1, pp. 116-126

2013

  1. Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm

    British Journal of Haematology, Vol. 161, Núm. 5, pp. 667-676

2012

  1. Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3

    British Journal of Haematology

2011

  1. Differential expression of JAK2 and Src kinase genes in response to hydroxyurea treatment in polycythemia vera and essential thrombocythemia

    Annals of Hematology, Vol. 90, Núm. 8, pp. 939-946